Expression and catalytic activity of the tyrosine phosphatase PTPIC is severely impaired in motheaten and viable motheaten mice

Journal of Experimental Medicine

Volumn 178, Issue 6, 1993, Pages 2157-2163

  Kozlowski, Maya ^a,b   Mlinaric Rascan, Irena ^a,b   Feng, Gen Sheng ^a,b,c   Shen, Randy ^a,b,c   Pawson, Tony ^a,b,c   Siminovitch, Katherine A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; HEMATOPOIESIS; HOMOZYGOSITY; IMMUNITY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMAL; BASE SEQUENCE; DNA PRIMERS; FEMALE; GENE EXPRESSION; HEMATOPOIESIS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; PEDIGREE; PHOSPHOPROTEINS; POINT MUTATION; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T;

EID: 0027359495     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.178.6.2157     Document Type: Article

References (30)

1. Green, M.C., and L.D. Shultz. 1975. Motheaten, an im-munodeficient mutant of the mouse. I. Genetics and Pathology. J. Hered.66:250.
2. Shultz, L.D., D.R. Coman, C.I. Bailey, W.G. Beamer, and C.L. Sidman. 1984. “Viable motheaten”, a new allele at the motheaten locus. I. Pathology. Am. J. Pathol. 116:179.
3. + B cells in viable motheaten and normal mice. Science (Wash. DC).232:1423.
4. Greiner, D.L., I. Goldschneider, K.L. Komschlies, E.S. Med-lock, F.J. Bollum, and L.D. Shultz. 1986. Defective lymphopoiesis in bone marrow of motheaten (me/me) and viable motheaten (me'/me') mutant mice. I. Analysis of the development of prothymocytes, early B lineage cells, and terminal deoxynucleotidyl transferase-positive cells. J. Exp. Med.164:1129.
5. Sidman, C.L., L.D. Shultz, and E.R. Unanue. 1978. The mouse mutant “motheaten.” II. Functional studies of the immune system. J. Immunol.121:2399.
6. Clark, E.A., L.D. Shultz, and S.B. Pollack. 1981. Mutations in mice that influence natural killer (NK) cell activity. 7m-munogenetics.12:601.
7. McCoy, K.L., E. Chi, D. Engel, and J. Clagett. 1983. Accelerated rate of mononuclear phagocyte production in vitro by splenocytes from autoimmune motheaten mice. Am.J. Pathol. 112:18.
8. Shultz, L.D., C.L. Bailey, and D.R. Coman. 1983. Haemopoietic stem cell function in motheaten mice. Exp Hematol. (NY).11:667.
9. Sidman, C.L., J.D. Marshall, and R.D. Allan. 1989. Murine “viable motheaten” mutation reveals a gene critical to the development of both B and T lymphocytes. Proc. Natl. Acad. Sci. USA.86:6279.
10. Tsui, H.W., K.A. Siminovitch, L. de Souza, and F.W.L. Tsui. 1993. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nature Genetics. 4:124.
11. Shen, S.-H., L. Bastien, R.I. Posner, and P. Chretien. 1991. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein tyrosine kinases. Nature (Lond.). 352:736.
12. Yi, T., J.L. Cleveland, and J.N. Ihle. 1992. Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in haemopoietic cells, and localization to human chromosome 12pl2-pl3. Mot Cell. Biol.12:836.
13. Plutzky, J., B.G. Neel, and R.D. Rosenberg. 1992. Isolation of a Src homology 2-containing tyrosine phosphatase. Proc Natl. Acad. Sci. USA.89:1123.
14. Matthews, R.J., D.B. Bowne, E. Flores, and M.L. Thomas. 1992. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol. Cell. Biol.12:2396.
15. Koch, C.A., D. Anderson, M. Moran, C. Ellis, and T. Pawson. 1991. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science (Wash. DC). 252:668.
16. Feng, G.-S., C.-C. Hui, and T. Pawson. 1993. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science (Wish. DC).259:1607.
17. Vogel, W., R. Lammers, J. Huang, and A. Ullrich. 1993. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science (Wash. DC).259:1611.
18. Perkins, L.A., I. Larsen, and N. Perrimon. 1992. corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso. Cell.70:225.
19. Shultz, L.D., P.A. Schweitzer, T.V. Rajan, T. Yi, J.N. Ihle, R.J. Matthews, M.L. Thomas, and D.R. Beier. 1993. Mutations at the murine motheaten locus are within the haemopoietic cell protein-tyrosine phosphatase (hcph) gene. Cell. 73:1445.
20. Yi, T., D.J. Gilbert, N.J. Jenkins, N.G. Copeland, and J.H. Ihle. 1992. Assignment of a novel protein tyrosine phosphatase gene (hcph) to mouse chromosome 6. Genomics.14:793.
21. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem.162:156.
22. Smith, D.B., and K.S. Johnson. 1988. Single step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (Amst.).67:31.
23. Simon, H.-U., G.B. Mills, S. Hashimoto, and K.A. Siminovitch. 1992. Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome. J. Clin. Invest. 90:1396.
24. Tonks, N.K., C.D. Diltz, and E.H. Fischer. 1988. Characterization of the major protein-tyrosine-phosphatases of human placenta. J. Biol. Chem.263:6731.
25. Picketts, D.J., C. Cameron, S.A.M. Taylor, K.V. Deugau, and D.P. Lillicrap. 1992. Differential termination of primer extension: a novel, quantifiable method for detection of point mutations. Hum. Genet.89:155.
26. Yeung, Y.G., K.L. Berg, F.J. Pixley, R.H. Angeletti, and E.R. Stanley. 1992. Protein tyrosine phosphatase-lC is rapidly phos-phorylated in tyrosine in macrophages in response to colony stimulating factor-1. J. Biol. Chem.267:23447.
27. Uchida, T., T. Matozaki, K. Matsuda, T. Suzuki, S. Matozaki, O. Nakana, K. Wada, Y. Konda, C. Sakamoto, and M. Kasuga. 1993. Phorbol ester stimulates the activity of a protein tyrosine phosphatase containing SH2 domains (PTP1C) in HL-60 leukemia cells by increasing gene expression. J. Biol. Chem. 268:11845.
28. Yi, T., and J.N. Ihle. 1993. Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand. Mol. Cell. Biol.13:3350.
29. Chabot, B., D.A. Stephenson, V.M. Chapman, P. Besmer, and A. Bernstein. 1988. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature (Lond.).335:88.
30. Sherr, C.J., C.W. Rettenmier, R. Sacca, M.F. Roussel, AT. Look, and E.R. Stanley. 1985. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell.41:665.